ARCHIVES

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

This article is from The Cancer Letter archive.

Vol. 38 No. 05 | February 3, 2012

Download PDF Visit The Full Archive

Related Articles

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990